Clinical Trial

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

Study acronym: OPPAÎ
Completed
View on ClinicalTrials.gov →
Summary
Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.
Protocol Amendment History 4 changes
critical Trial completed 2026-08-12
notable Enrollment reduced: 128 -> 59 participants 2026-08-12
notable Primary completion moved earlier: 2028-10 -> 2024-10-03 2026-08-12
minor Completion moved earlier: 2028-10 -> 2024-10-03 2026-08-12
Trial Details
NCT Number NCT03527992
Lead Sponsor University Hospital, Toulouse
Conditions Pneumonia, Pneumonia, Ventilator-Associated, Length of Stay
Enrollment 59 participants
Start Date 2018-03-09
Primary Completion 2024-10-03 (estimated)
Study Completion 2024-10-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-11